Centene (CNC) Revenue — Quarter Ended Jun 30, 2025
Revenue for the quarter was essentially unchanged from the immediately preceding quarter but rose sharply compared with the same quarter one year earlier. The sequential stability contrasts with the strong year-over-year growth.
Key takeaway
Quarter ended Jun 30, 2025 · FY2025 Q2
Revenue for the quarter was essentially unchanged from the immediately preceding quarter but rose sharply compared with the same quarter one year earlier. The sequential stability contrasts with the strong year-over-year growth.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$42.5B
Revenue reported for this quarter.
Quarter-over-quarter
-0.1%
Change from the immediately preceding quarter.
Year-over-year
+18.1%
Change from the comparable year-ago quarter.
Trailing four quarters
$158.2B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2024 | $36.9B | +5.5% |
| Dec 31, 2024 | $36.3B | +2.7% |
| Mar 31, 2025 | $42.5B | +16.9% |
| Jun 30, 2025 | $42.5B | +18.1% |
Revenue performance
The reported revenue level was flat relative to the prior quarter, while the trailing twelve-month revenue reflected a higher run rate. Year-over-year, the quarter showed a significant increase.
Quarterly comparison
Compared with the immediately preceding quarter, revenue was nearly flat with a negligible decline. Compared with the same quarter one year earlier, revenue was substantially higher.
What to watch
Filing commentary noted improved pharmacy rebate remittance timing as a driver of operating cash flow, but no specific causal link to revenue was provided.